speb/financial-data huggingface dataset:
IMMP cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -225414.00
IMMP cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -35170319.00
IMMP cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -10501.00
IMMP cash_flow (quarterly, 2024-12-31) — Receiptsfrom Customers: 8000.00
IMMP cash_flow (quarterly, 2024-12-31) — Receiptsfrom Government Grants: 66405.00
IMMP balance_sheet (quarterly, 2024-12-31) — Receivables: 7925086.00
IMMP cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -118222.00
IMMP balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -405024586.00
IMMP cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
IMMP cash_flow (quarterly, 2024-12-31) — Sale Of Intangibles: 0.00
IMMP cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 5000000.00
IMMP cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
IMMP balance_sheet (quarterly, 2024-12-31) — Share Issued: 1455589575.00
IMMP balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 172472206.00
IMMP balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 164695436.00
IMMP balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 1299166.00
IMMP cash_flow (quarterly, 2024-12-31) — Taxes Refund Paid Direct: 0.00
IMMP balance_sheet (quarterly, 2024-12-31) — Total Assets: 182328516.00
IMMP balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 172472206.00
IMMP balance_sheet (quarterly, 2024-12-31) — Total Debt: 1684817.00
IMMP balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 172472206.00
IMMP balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 9856310.00
IMMP balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 8564455.00
IMMP balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 644317.00
IMMP balance_sheet (quarterly, 2024-12-31) — Working Capital: 164552068.00
IMMP cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 73887000.00
IMMP cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -50085.00
IMMP cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -65000.00
IMMP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 32342000.00
IMMP cash_flow (quarterly, 2025-03-31) — Cash Flowsfromusedin Operating Activities Direct: -16262000.00
IMMP cash_flow (quarterly, 2025-03-31) — Changes In Cash: 16015000.00
IMMP cash_flow (quarterly, 2025-03-31) — Classesof Cash Payments: -17076000.00
IMMP cash_flow (quarterly, 2025-03-31) — Classesof Cash Receiptsfrom Operating Activities: 12000.00
IMMP cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Dividends Received Cfi: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Dividends Received Direct: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 2549000.00
IMMP cash_flow (quarterly, 2025-03-31) — End Cash Position: 92451000.00
IMMP cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -65000.00
IMMP cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -16262000.00
IMMP cash_flow (quarterly, 2025-03-31) — Interest Paid Direct: -8000.00
IMMP cash_flow (quarterly, 2025-03-31) — Interest Received Direct: 810000.00
IMMP cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 32342000.00
IMMP cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -65000.00
IMMP cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 32342000.00
IMMP cash_flow (quarterly, 2025-03-31) — Other Cash Paymentsfrom Operating Activities: -984000.00
IMMP cash_flow (quarterly, 2025-03-31) — Paymentson Behalfof Employees: -2500000.00
IMMP cash_flow (quarterly, 2025-03-31) — Paymentsto Suppliersfor Goodsand Services: -13592000.00
IMMP cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Receiptsfrom Customers: 12000.00
IMMP cash_flow (quarterly, 2025-03-31) — Receiptsfrom Government Grants: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Sale Of Business: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Sale Of Intangibles: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
IMMP cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 32342000.00
IMMP cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid Direct: 0.00
IMMP income_statement (annual, 2025-06-30) — Basic Average Shares: 145581844.00
IMMP income_statement (annual, 2025-06-30) — Basic EPS: -0.42
IMMP income_statement (annual, 2025-06-30) — Diluted Average Shares: 145581844.00
IMMP income_statement (annual, 2025-06-30) — Diluted EPS: -0.42
IMMP balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 9029033.00
IMMP balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 29907896.00
IMMP balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -765022.00
IMMP cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 83413000.00
IMMP balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 1185361.00
IMMP cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -87657.00
IMMP balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1209606.00
IMMP balance_sheet (quarterly, 2025-12-31) — Capital Stock: 547652181.00
IMMP balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 72747858.00
IMMP balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 99129499.00
IMMP cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
IMMP balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 29649828.00
IMMP balance_sheet (quarterly, 2025-12-31) — Cash Financial: 43098030.00
IMMP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -40554.00
IMMP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -139781.00
IMMP cash_flow (quarterly, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: -9612546.00
IMMP cash_flow (quarterly, 2025-12-31) — Changes In Cash: -9792881.00
IMMP cash_flow (quarterly, 2025-12-31) — Classesof Cash Payments: -14562255.00
IMMP cash_flow (quarterly, 2025-12-31) — Classesof Cash Receiptsfrom Operating Activities: 4587115.00
IMMP balance_sheet (quarterly, 2025-12-31) — Common Stock: 547652181.00
IMMP balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 98898788.00
IMMP cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
IMMP balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 10251239.00
IMMP balance_sheet (quarterly, 2025-12-31) — Current Assets: 139787137.00
IMMP balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 260004.00
IMMP balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 260004.00
IMMP balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 25827536.00
IMMP balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 25827536.00
IMMP balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 47012102.00
IMMP cash_flow (quarterly, 2025-12-31) — Dividends Received Cfi: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Dividends Received Direct: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -872476.00
IMMP balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 313013.00
IMMP cash_flow (quarterly, 2025-12-31) — End Cash Position: 72747858.00
IMMP cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -40554.00
IMMP cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -9700203.00
IMMP balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 37598164.00
IMMP balance_sheet (quarterly, 2025-12-31) — Goodwill: 109962.00
IMMP balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 5954850.00
IMMP balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2083166.00
IMMP balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Interest Paid Direct: -6976.00
IMMP cash_flow (quarterly, 2025-12-31) — Interest Received Direct: 369570.00
IMMP balance_sheet (quarterly, 2025-12-31) — Invested Capital: 98898788.00
IMMP cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -139781.00
IMMP cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
IMMP balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 949602.00
IMMP balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 949602.00
IMMP cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -112554.00
IMMP balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 28391.00
IMMP balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 897805.00
IMMP cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -52124.00
IMMP cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -112554.00
IMMP cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -112554.00
IMMP cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -44000.00
IMMP cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -55000.00
IMMP balance_sheet (quarterly, 2025-12-31) — Net PPE: 1318144.00
IMMP cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -87657.00
IMMP balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 92943938.00
IMMP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 0.00
IMMP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 0.00
IMMP balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1473721306.00
IMMP cash_flow (quarterly, 2025-12-31) — Other Cash Paymentsfrom Operating Activities: -1878000.00
IMMP balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 503101.00
IMMP balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 5844888.00
IMMP balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 141765.00
IMMP balance_sheet (quarterly, 2025-12-31) — Other Payable: 397159.00
IMMP balance_sheet (quarterly, 2025-12-31) — Other Receivables: 6472838.00
IMMP balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 26381641.00
IMMP balance_sheet (quarterly, 2025-12-31) — Payables: 9426192.00
IMMP balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 19677431.00
IMMP cash_flow (quarterly, 2025-12-31) — Paymentson Behalfof Employees: -2608000.00
IMMP cash_flow (quarterly, 2025-12-31) — Paymentsto Suppliersfor Goodsand Services: -19083255.00
IMMP balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 744030.00
IMMP balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 3137272.00
IMMP cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
IMMP balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -87657.00
IMMP cash_flow (quarterly, 2025-12-31) — Receiptsfrom Customers: 4000.00
IMMP cash_flow (quarterly, 2025-12-31) — Receiptsfrom Government Grants: 4582654.00
IMMP balance_sheet (quarterly, 2025-12-31) — Receivables: 37520366.00
IMMP cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -112554.00
IMMP balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -486351557.00
IMMP cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Sale Of Intangibles: 0.00
IMMP cash_flow (quarterly, 2025-12-31) — Sale Of Investment: -52124.00
IMMP cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
IMMP balance_sheet (quarterly, 2025-12-31) — Share Issued: 1473721306.00
IMMP balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 98898788.00
IMMP balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 92943938.00
IMMP balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 1139632.00
IMMP cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid Direct: 0.00
IMMP balance_sheet (quarterly, 2025-12-31) — Total Assets: 147201896.00
IMMP balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 98898788.00
IMMP balance_sheet (quarterly, 2025-12-31) — Total Debt: 1209606.00
IMMP balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 98898788.00
IMMP balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 48303108.00
IMMP balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 7414759.00
IMMP balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1291006.00
IMMP balance_sheet (quarterly, 2025-12-31) — Working Capital: 92775035.00
IMMP cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 72747000.00
IMMP cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -5000.00
IMMP cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -37000.00
IMMP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 20000.00
IMMP cash_flow (quarterly, 2026-03-31) — Cash Flowsfromusedin Operating Activities Direct: 13510000.00
IMMP cash_flow (quarterly, 2026-03-31) — Changes In Cash: 11530000.00
IMMP cash_flow (quarterly, 2026-03-31) — Classesof Cash Payments: -15683000.00
IMMP cash_flow (quarterly, 2026-03-31) — Classesof Cash Receiptsfrom Operating Activities: 28848000.00
IMMP cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Dividends Received Cfi: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Dividends Received Direct: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — End Cash Position: 84277000.00
IMMP cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -37000.00
IMMP cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 13505000.00
IMMP cash_flow (quarterly, 2026-03-31) — Interest Paid Direct: -7000.00
IMMP cash_flow (quarterly, 2026-03-31) — Interest Received Direct: 352000.00
IMMP cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 20000.00
IMMP cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -37000.00
IMMP cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 25000.00
IMMP cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -5000.00
IMMP cash_flow (quarterly, 2026-03-31) — Other Cash Paymentsfrom Operating Activities: -1291000.00
IMMP cash_flow (quarterly, 2026-03-31) — Paymentson Behalfof Employees: -2627000.00
IMMP cash_flow (quarterly, 2026-03-31) — Paymentsto Suppliersfor Goodsand Services: -11765000.00
IMMP cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -5000.00
IMMP cash_flow (quarterly, 2026-03-31) — Receiptsfrom Customers: 28848000.00
IMMP cash_flow (quarterly, 2026-03-31) — Receiptsfrom Government Grants: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Sale Of Business: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Sale Of Intangibles: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
IMMP cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid Direct: 0.00
IMMR income_statement (annual, 2021-12-31) — +Operating Expense: 17226000.00
IMMR income_statement (annual, 2021-12-31) — +Total Revenue: 35089000.00
IMMR balance_sheet (annual, 2021-12-31) — Accounts Payable: 2000.00
IMMR balance_sheet (annual, 2021-12-31) — Accounts Receivable: 1235000.00
IMMR cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 2829000.00
IMMR balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 7286000.00
IMMR income_statement (annual, 2021-12-31) — Basic Average Shares: 31459000.00
IMMR income_statement (annual, 2021-12-31) — Basic EPS: 0.40
IMMR cash_flow (annual, 2021-12-31) — Beginning Cash Position: 59522000.00
IMMR cash_flow (annual, 2021-12-31) — Capital Expenditure: -335000.00
IMMR balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 1098000.00
IMMR balance_sheet (annual, 2021-12-31) — Capital Stock: 323296000.00
IMMR balance_sheet (annual, 2021-12-31) — Cash And Cash Equivalents: 51490000.00
IMMR balance_sheet (annual, 2021-12-31) — Cash Cash Equivalents And Short Term Investments: 137921000.00
IMMR balance_sheet (annual, 2021-12-31) — Cash Equivalents: 0.00
IMMR balance_sheet (annual, 2021-12-31) — Cash Financial: 51490000.00
IMMR cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Financing Activities: 62203000.00
IMMR cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Investing Activities: -87684000.00
IMMR cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Operating Activities: 17449000.00
IMMR cash_flow (annual, 2021-12-31) — Change In Account Payable: -148000.00
IMMR cash_flow (annual, 2021-12-31) — Change In Accrued Expense: -446000.00
IMMR cash_flow (annual, 2021-12-31) — Change In Other Current Assets: 2952000.00
IMMR cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: 714000.00
IMMR cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -4982000.00
IMMR cash_flow (annual, 2021-12-31) — Change In Payable: -148000.00
IMMR cash_flow (annual, 2021-12-31) — Change In Payables And Accrued Expense: -594000.00
IMMR cash_flow (annual, 2021-12-31) — Change In Prepaid Assets: -713000.00
IMMR cash_flow (annual, 2021-12-31) — Change In Receivables: 248000.00
IMMR cash_flow (annual, 2021-12-31) — Change In Working Capital: -2375000.00
IMMR cash_flow (annual, 2021-12-31) — Changes In Cash: -8032000.00
IMMR balance_sheet (annual, 2021-12-31) — Common Stock: 323296000.00
IMMR balance_sheet (annual, 2021-12-31) — Common Stock Equity: 141295000.00
IMMR cash_flow (annual, 2021-12-31) — Common Stock Issuance: 59189000.00
IMMR cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
IMMR income_statement (annual, 2021-12-31) — Cost Of Revenue: 88000.00
IMMR balance_sheet (annual, 2021-12-31) — Current Assets: 153323000.00
IMMR balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 1098000.00
IMMR balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 1098000.00
IMMR balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 4826000.00
IMMR balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 4826000.00
IMMR balance_sheet (annual, 2021-12-31) — Current Liabilities: 16630000.00
IMMR cash_flow (annual, 2021-12-31) — Deferred Income Tax: 531000.00
IMMR cash_flow (annual, 2021-12-31) — Deferred Tax: 531000.00
IMMR cash_flow (annual, 2021-12-31) — Depreciation: 99000.00
IMMR cash_flow (annual, 2021-12-31) — Depreciation Amortization Depletion: 99000.00
IMMR cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 99000.00
IMMR income_statement (annual, 2021-12-31) — Diluted Average Shares: 31769000.00
IMMR income_statement (annual, 2021-12-31) — Diluted EPS: 0.39
IMMR income_statement (annual, 2021-12-31) — Diluted NI Availto Com Stockholders: 12484000.00
IMMR income_statement (annual, 2021-12-31) — EBIT: 17775000.00
IMMR income_statement (annual, 2021-12-31) — EBITDA: 17874000.00
IMMR cash_flow (annual, 2021-12-31) — End Cash Position: 51490000.00
IMMR cash_flow (annual, 2021-12-31) — Financing Cash Flow: 62203000.00
IMMR cash_flow (annual, 2021-12-31) — Free Cash Flow: 17114000.00
IMMR cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 885000.00
IMMR balance_sheet (annual, 2021-12-31) — Gains Losses Not Affecting Retained Earnings: 412000.00
IMMR income_statement (annual, 2021-12-31) — General And Administrative Expense: 9835000.00
IMMR balance_sheet (annual, 2021-12-31) — Gross PPE: 1356000.00
IMMR income_statement (annual, 2021-12-31) — Gross Profit: 35001000.00
IMMR cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 88000.00
IMMR balance_sheet (annual, 2021-12-31) — Income Tax Payable: 2057000.00
IMMR income_statement (annual, 2021-12-31) — Interest Income: 374000.00
IMMR income_statement (annual, 2021-12-31) — Interest Income Non Operating: 374000.00
IMMR balance_sheet (annual, 2021-12-31) — Invested Capital: 141295000.00
IMMR cash_flow (annual, 2021-12-31) — Investing Cash Flow: -87684000.00
IMMR balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 7286000.00
IMMR balance_sheet (annual, 2021-12-31) — Investments And Advances: 7286000.00
IMMR cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 59189000.00
IMMR cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 59189000.00
IMMR cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: 635000.00
IMMR income_statement (annual, 2021-12-31) — Net Income: 12484000.00
IMMR income_statement (annual, 2021-12-31) — Net Income Common Stockholders: 12484000.00
IMMR income_statement (annual, 2021-12-31) — Net Income Continuous Operations: 12484000.00
IMMR income_statement (annual, 2021-12-31) — Net Income From Continuing And Discontinued Operation: 12484000.00
IMMR income_statement (annual, 2021-12-31) — Net Income From Continuing Operation Net Minority Interest: 12484000.00
IMMR cash_flow (annual, 2021-12-31) — Net Income From Continuing Operations: 12484000.00
IMMR income_statement (annual, 2021-12-31) — Net Income Including Noncontrolling Interests: 12484000.00
IMMR income_statement (annual, 2021-12-31) — Net Interest Income: 374000.00
IMMR cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: -87349000.00
IMMR income_statement (annual, 2021-12-31) — Net Non Operating Interest Income Expense: 374000.00
IMMR balance_sheet (annual, 2021-12-31) — Net PPE: 1356000.00
IMMR cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -335000.00
IMMR balance_sheet (annual, 2021-12-31) — Net Tangible Assets: 141295000.00
IMMR balance_sheet (annual, 2021-12-31) — Non Current Accounts Receivable: 1746000.00
IMMR balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 2115000.00
IMMR balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 16699000.00
IMMR balance_sheet (annual, 2021-12-31) — Non Current Deferred Revenue: 16699000.00
IMMR balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 2115000.00
IMMR balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 9658000.00
IMMR income_statement (annual, 2021-12-31) — Normalized EBITDA: 17874000.00
IMMR income_statement (annual, 2021-12-31) — Normalized Income: 12484000.00
IMMR cash_flow (annual, 2021-12-31) — Operating Cash Flow: 17449000.00
IMMR cash_flow (annual, 2021-12-31) — Operating Gains Losses: 1520000.00
IMMR income_statement (annual, 2021-12-31) — Operating Income: 17775000.00
IMMR income_statement (annual, 2021-12-31) — Operating Revenue: 35089000.00
IMMR balance_sheet (annual, 2021-12-31) — Ordinary Shares Number: 34390765.00
IMMR balance_sheet (annual, 2021-12-31) — Other Current Assets: 186000.00
IMMR balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 8092000.00
IMMR balance_sheet (annual, 2021-12-31) — Other Equity Adjustments: 412000.00
IMMR income_statement (annual, 2021-12-31) — Other Gand A: 9835000.00
IMMR income_statement (annual, 2021-12-31) — Other Income Expense: -859000.00
IMMR balance_sheet (annual, 2021-12-31) — Other Investments: 7286000.00
IMMR cash_flow (annual, 2021-12-31) — Other Non Cash Items: 23000.00
IMMR balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 36000.00
IMMR balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 896000.00
IMMR income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -859000.00
IMMR balance_sheet (annual, 2021-12-31) — Other Properties: 1356000.00
IMMR balance_sheet (annual, 2021-12-31) — Other Receivables: 13183000.00
IMMR balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 86431000.00
IMMR balance_sheet (annual, 2021-12-31) — Payables: 2059000.00
IMMR balance_sheet (annual, 2021-12-31) — Payables And Accrued Expenses: 2059000.00
IMMR balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 555000.00
IMMR balance_sheet (annual, 2021-12-31) — Prepaid Assets: 798000.00
IMMR income_statement (annual, 2021-12-31) — Pretax Income: 17290000.00
IMMR cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 3014000.00
IMMR cash_flow (annual, 2021-12-31) — Purchase Of Investment: -123424000.00
IMMR cash_flow (annual, 2021-12-31) — Purchase Of PPE: -335000.00
IMMR balance_sheet (annual, 2021-12-31) — Receivables: 14418000.00
IMMR income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 88000.00
IMMR income_statement (annual, 2021-12-31) — Reconciled Depreciation: 99000.00
IMMR cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
IMMR income_statement (annual, 2021-12-31) — Research And Development: 4150000.00
IMMR balance_sheet (annual, 2021-12-31) — Retained Earnings: -100680000.00
IMMR cash_flow (annual, 2021-12-31) — Sale Of Investment: 36075000.00
IMMR cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
IMMR income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 3241000.00
IMMR income_statement (annual, 2021-12-31) — Selling General And Administration: 13076000.00
IMMR balance_sheet (annual, 2021-12-31) — Share Issued: 46534198.00
IMMR cash_flow (annual, 2021-12-31) — Stock Based Compensation: 2338000.00
IMMR balance_sheet (annual, 2021-12-31) — Stockholders Equity: 141295000.00
IMMR balance_sheet (annual, 2021-12-31) — Tangible Book Value: 141295000.00
IMMR income_statement (annual, 2021-12-31) — Tax Effect Of Unusual Items: 0.00
IMMR income_statement (annual, 2021-12-31) — Tax Provision: 4806000.00
IMMR income_statement (annual, 2021-12-31) — Tax Rate For Calcs: 0.28
IMMR balance_sheet (annual, 2021-12-31) — Total Assets: 175520000.00
IMMR balance_sheet (annual, 2021-12-31) — Total Capitalization: 141295000.00
IMMR balance_sheet (annual, 2021-12-31) — Total Debt: 1098000.00
IMMR balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: 141295000.00
IMMR income_statement (annual, 2021-12-31) — Total Expenses: 17314000.00
IMMR balance_sheet (annual, 2021-12-31) — Total Liabilities Net Minority Interest: 34225000.00
IMMR balance_sheet (annual, 2021-12-31) — Total Non Current Assets: 22197000.00
IMMR balance_sheet (annual, 2021-12-31) — Total Non Current Liabilities Net Minority Interest: 17595000.00
IMMR income_statement (annual, 2021-12-31) — Total Operating Income As Reported: 17775000.00
IMMR balance_sheet (annual, 2021-12-31) — Total Tax Payable: 2057000.00
IMMR balance_sheet (annual, 2021-12-31) — Treasury Shares Number: 12143433.00
IMMR balance_sheet (annual, 2021-12-31) — Treasury Stock: 81733000.00
IMMR balance_sheet (annual, 2021-12-31) — Working Capital: 136693000.00
IMMR income_statement (annual, 2022-12-31) — +Operating Expense: 14041000.00
IMMR income_statement (annual, 2022-12-31) — +Total Revenue: 38461000.00
IMMR balance_sheet (annual, 2022-12-31) — Accounts Payable: 86000.00
IMMR balance_sheet (annual, 2022-12-31) — Accounts Receivable: 1003000.00
IMMR cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 672000.00
IMMR balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 17040000.00
IMMR income_statement (annual, 2022-12-31) — Basic Average Shares: 33280000.00
IMMR income_statement (annual, 2022-12-31) — Basic EPS: 0.92
IMMR cash_flow (annual, 2022-12-31) — Beginning Cash Position: 51490000.00
IMMR cash_flow (annual, 2022-12-31) — Capital Expenditure: -30000.00
IMMR balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 486000.00
IMMR balance_sheet (annual, 2022-12-31) — Capital Stock: 322714000.00
IMMR balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 48820000.00
IMMR balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 149738000.00
IMMR cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
IMMR balance_sheet (annual, 2022-12-31) — Cash Equivalents: 39190000.00
IMMR balance_sheet (annual, 2022-12-31) — Cash Financial: 9630000.00
IMMR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -13411000.00
IMMR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -29405000.00
IMMR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 40146000.00
IMMR cash_flow (annual, 2022-12-31) — Change In Account Payable: 84000.00
IMMR cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 1474000.00
IMMR cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 1226000.00
IMMR cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -1694000.00
IMMR cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -4130000.00
IMMR cash_flow (annual, 2022-12-31) — Change In Payable: 84000.00
IMMR cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1558000.00
IMMR cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 9281000.00
IMMR cash_flow (annual, 2022-12-31) — Change In Receivables: 735000.00
IMMR cash_flow (annual, 2022-12-31) — Change In Working Capital: 6976000.00
IMMR cash_flow (annual, 2022-12-31) — Changes In Cash: -2670000.00
IMMR balance_sheet (annual, 2022-12-31) — Common Stock: 322714000.00
IMMR cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: 0.00
IMMR balance_sheet (annual, 2022-12-31) — Common Stock Equity: 157700000.00
IMMR cash_flow (annual, 2022-12-31) — Common Stock Issuance: 5000.00
IMMR cash_flow (annual, 2022-12-31) — Common Stock Payments: -13238000.00
IMMR income_statement (annual, 2022-12-31) — Cost Of Revenue: 4000.00
IMMR balance_sheet (annual, 2022-12-31) — Current Assets: 160320000.00
IMMR balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 486000.00
IMMR balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 486000.00
IMMR balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 4766000.00
IMMR balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 4766000.00
IMMR balance_sheet (annual, 2022-12-31) — Current Liabilities: 17925000.00
IMMR cash_flow (annual, 2022-12-31) — Deferred Income Tax: -5101000.00
IMMR cash_flow (annual, 2022-12-31) — Deferred Tax: -5101000.00
IMMR cash_flow (annual, 2022-12-31) — Depreciation: 140000.00
IMMR cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 140000.00
IMMR cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 140000.00
IMMR income_statement (annual, 2022-12-31) — Diluted Average Shares: 33508000.00
IMMR income_statement (annual, 2022-12-31) — Diluted EPS: 0.92
IMMR income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 30664000.00
IMMR balance_sheet (annual, 2022-12-31) — Dividends Payable: 4212000.00
IMMR income_statement (annual, 2022-12-31) — EBIT: 24420000.00
IMMR income_statement (annual, 2022-12-31) — EBITDA: 24560000.00
IMMR cash_flow (annual, 2022-12-31) — End Cash Position: 48820000.00
IMMR cash_flow (annual, 2022-12-31) — Financing Cash Flow: -13411000.00
IMMR cash_flow (annual, 2022-12-31) — Free Cash Flow: 40146000.00
IMMR cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 3053000.00
IMMR balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 202000.00
IMMR income_statement (annual, 2022-12-31) — General And Administrative Expense: 11442000.00
IMMR balance_sheet (annual, 2022-12-31) — Gross PPE: 653000.00
IMMR income_statement (annual, 2022-12-31) — Gross Profit: 38457000.00
IMMR cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1408000.00
IMMR balance_sheet (annual, 2022-12-31) — Income Tax Payable: 1279000.00
IMMR income_statement (annual, 2022-12-31) — Interest Income: 2838000.00
IMMR income_statement (annual, 2022-12-31) — Interest Income Non Operating: 2838000.00
IMMR balance_sheet (annual, 2022-12-31) — Invested Capital: 157700000.00
IMMR cash_flow (annual, 2022-12-31) — Investing Cash Flow: -29405000.00
IMMR balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 17040000.00
IMMR balance_sheet (annual, 2022-12-31) — Investments And Advances: 17040000.00
IMMR cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 5000.00
IMMR cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -13238000.00
IMMR cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 145000.00
IMMR income_statement (annual, 2022-12-31) — Net Income: 30664000.00
IMMR income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 30664000.00
IMMR income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 30664000.00
IMMR income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 30664000.00
IMMR income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 30664000.00
IMMR cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 30664000.00
IMMR income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 30664000.00
IMMR income_statement (annual, 2022-12-31) — Net Interest Income: 2838000.00
IMMR cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -29379000.00
IMMR income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 2838000.00
IMMR cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -173000.00
IMMR cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -26000.00
IMMR balance_sheet (annual, 2022-12-31) — Net PPE: 653000.00
IMMR cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -26000.00
IMMR balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 157700000.00
IMMR balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 545000.00
IMMR balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 7217000.00
IMMR balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 12629000.00
IMMR balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 12629000.00
IMMR balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 7217000.00
IMMR balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 4324000.00
IMMR income_statement (annual, 2022-12-31) — Normalized EBITDA: 24560000.00
IMMR income_statement (annual, 2022-12-31) — Normalized Income: 30664000.00
IMMR cash_flow (annual, 2022-12-31) — Operating Cash Flow: 40146000.00
IMMR cash_flow (annual, 2022-12-31) — Operating Gains Losses: 3198000.00
IMMR income_statement (annual, 2022-12-31) — Operating Income: 24420000.00
IMMR income_statement (annual, 2022-12-31) — Operating Revenue: 38461000.00
IMMR balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 32247047.00
IMMR balance_sheet (annual, 2022-12-31) — Other Current Assets: 100000.00
IMMR balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 5067000.00
IMMR balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 202000.00
IMMR income_statement (annual, 2022-12-31) — Other Gand A: 11442000.00
IMMR income_statement (annual, 2022-12-31) — Other Income Expense: -293000.00
IMMR cash_flow (annual, 2022-12-31) — Other Non Cash Items: 695000.00
IMMR balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 11000.00
IMMR balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1856000.00
IMMR income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -293000.00
IMMR balance_sheet (annual, 2022-12-31) — Other Properties: 653000.00
IMMR balance_sheet (annual, 2022-12-31) — Other Receivables: 7903000.00
IMMR balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 100918000.00
IMMR balance_sheet (annual, 2022-12-31) — Payables: 5577000.00
IMMR balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 5577000.00
IMMR balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2029000.00
IMMR balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1576000.00
IMMR income_statement (annual, 2022-12-31) — Pretax Income: 26965000.00
IMMR cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
IMMR cash_flow (annual, 2022-12-31) — Purchase Of Investment: -165358000.00
IMMR cash_flow (annual, 2022-12-31) — Purchase Of PPE: -30000.00
IMMR balance_sheet (annual, 2022-12-31) — Receivables: 8906000.00
IMMR income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 4000.00
IMMR income_statement (annual, 2022-12-31) — Reconciled Depreciation: 140000.00
IMMR cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -13238000.00
IMMR income_statement (annual, 2022-12-31) — Research And Development: 1380000.00
IMMR balance_sheet (annual, 2022-12-31) — Retained Earnings: -70016000.00
IMMR cash_flow (annual, 2022-12-31) — Sale Of Investment: 135979000.00
IMMR cash_flow (annual, 2022-12-31) — Sale Of PPE: 4000.00
IMMR income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 1219000.00
IMMR income_statement (annual, 2022-12-31) — Selling General And Administration: 12661000.00
IMMR balance_sheet (annual, 2022-12-31) — Share Issued: 46974629.00
IMMR cash_flow (annual, 2022-12-31) — Stock Based Compensation: 3574000.00
IMMR balance_sheet (annual, 2022-12-31) — Stockholders Equity: 157700000.00
IMMR balance_sheet (annual, 2022-12-31) — Tangible Book Value: 157700000.00
IMMR income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
IMMR income_statement (annual, 2022-12-31) — Tax Provision: -3699000.00
IMMR income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
IMMR balance_sheet (annual, 2022-12-31) — Total Assets: 190110000.00
IMMR balance_sheet (annual, 2022-12-31) — Total Capitalization: 157700000.00
IMMR balance_sheet (annual, 2022-12-31) — Total Debt: 486000.00
IMMR balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 157700000.00
IMMR income_statement (annual, 2022-12-31) — Total Expenses: 14041000.00
IMMR balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 32410000.00
IMMR balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 29790000.00
IMMR balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 14485000.00
IMMR income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 24420000.00
IMMR income_statement (annual, 2022-12-31) — Total Other Finance Cost: -2838000.00
IMMR balance_sheet (annual, 2022-12-31) — Total Tax Payable: 1279000.00
IMMR balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 14727582.00
IMMR balance_sheet (annual, 2022-12-31) — Treasury Stock: 95200000.00
IMMR balance_sheet (annual, 2022-12-31) — Working Capital: 142395000.00
IMMR income_statement (annual, 2023-12-31) — +Operating Expense: 15992000.00
IMMR income_statement (annual, 2023-12-31) — +Total Revenue: 33919000.00
IMMR balance_sheet (annual, 2023-12-31) — Accounts Payable: 47000.00
IMMR balance_sheet (annual, 2023-12-31) — Accounts Receivable: 1743000.00
IMMR balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 33350000.00
IMMR income_statement (annual, 2023-12-31) — Basic Average Shares: 32214000.00
IMMR income_statement (annual, 2023-12-31) — Basic EPS: 1.05
IMMR cash_flow (annual, 2023-12-31) — Beginning Cash Position: 48820000.00
IMMR balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 39000.00
IMMR balance_sheet (annual, 2023-12-31) — Capital Stock: 322182000.00
IMMR balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 56071000.00
IMMR balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 160362000.00
IMMR cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -7409000.00
IMMR balance_sheet (annual, 2023-12-31) — Cash Equivalents: 41231000.00
IMMR balance_sheet (annual, 2023-12-31) — Cash Financial: 14840000.00
IMMR cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -16747000.00
IMMR cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 3398000.00
IMMR cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 20600000.00
IMMR cash_flow (annual, 2023-12-31) — Change In Account Payable: -41000.00
IMMR cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 1098000.00
IMMR cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 446000.00
IMMR cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 2437000.00
IMMR cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -4766000.00
IMMR cash_flow (annual, 2023-12-31) — Change In Payable: -41000.00
IMMR cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 1057000.00
IMMR cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -2350000.00
IMMR cash_flow (annual, 2023-12-31) — Change In Receivables: -1006000.00
IMMR cash_flow (annual, 2023-12-31) — Change In Working Capital: -4182000.00
IMMR cash_flow (annual, 2023-12-31) — Changes In Cash: 7251000.00
IMMR balance_sheet (annual, 2023-12-31) — Common Stock: 322182000.00
IMMR cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -7409000.00
IMMR balance_sheet (annual, 2023-12-31) — Common Stock Equity: 183102000.00
IMMR cash_flow (annual, 2023-12-31) — Common Stock Payments: -8264000.00
IMMR balance_sheet (annual, 2023-12-31) — Current Assets: 172450000.00
IMMR balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 39000.00
IMMR balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 39000.00
IMMR balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 4239000.00
IMMR balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 4239000.00
IMMR balance_sheet (annual, 2023-12-31) — Current Liabilities: 19313000.00
IMMR cash_flow (annual, 2023-12-31) — Deferred Income Tax: 3528000.00
IMMR cash_flow (annual, 2023-12-31) — Deferred Tax: 3528000.00
IMMR cash_flow (annual, 2023-12-31) — Depreciation: 67000.00
IMMR cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 67000.00
IMMR cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 67000.00
IMMR income_statement (annual, 2023-12-31) — Diluted Average Shares: 32536000.00
IMMR income_statement (annual, 2023-12-31) — Diluted EPS: 1.04
IMMR income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 33976000.00
IMMR balance_sheet (annual, 2023-12-31) — Dividends Payable: 1489000.00
IMMR income_statement (annual, 2023-12-31) — EBIT: 17927000.00
IMMR income_statement (annual, 2023-12-31) — EBITDA: 17994000.00
IMMR cash_flow (annual, 2023-12-31) — End Cash Position: 56071000.00
IMMR cash_flow (annual, 2023-12-31) — Financing Cash Flow: -16747000.00
IMMR cash_flow (annual, 2023-12-31) — Free Cash Flow: 20600000.00
IMMR cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -16798000.00
IMMR balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 1702000.00
IMMR income_statement (annual, 2023-12-31) — General And Administrative Expense: 13960000.00
IMMR balance_sheet (annual, 2023-12-31) — Gross PPE: 247000.00
IMMR cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 1794000.00
IMMR balance_sheet (annual, 2023-12-31) — Income Tax Payable: 1730000.00
IMMR balance_sheet (annual, 2023-12-31) — Invested Capital: 183102000.00
IMMR cash_flow (annual, 2023-12-31) — Investing Cash Flow: 3398000.00
IMMR balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 33350000.00
IMMR balance_sheet (annual, 2023-12-31) — Investments And Advances: 33350000.00
IMMR cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -8264000.00
IMMR cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -43000.00
IMMR income_statement (annual, 2023-12-31) — Net Income: 33976000.00
IMMR income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 33976000.00
IMMR income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 33976000.00
IMMR income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 33976000.00
IMMR income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 33976000.00
IMMR cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 33976000.00
IMMR income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 33976000.00
IMMR income_statement (annual, 2023-12-31) — Net Interest Income: 25008000.00
IMMR cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 3398000.00
IMMR income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 25008000.00
IMMR cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -1234000.00
IMMR balance_sheet (annual, 2023-12-31) — Net PPE: 247000.00
IMMR balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 183102000.00
IMMR balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 110000.00
IMMR balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 3343000.00
IMMR balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 8390000.00
IMMR balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 8390000.00
IMMR balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 3343000.00
IMMR balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 6231000.00
IMMR income_statement (annual, 2023-12-31) — Normalized EBITDA: 17994000.00
IMMR income_statement (annual, 2023-12-31) — Normalized Income: 33976000.00
IMMR cash_flow (annual, 2023-12-31) — Operating Cash Flow: 20600000.00
IMMR cash_flow (annual, 2023-12-31) — Operating Gains Losses: -16841000.00
IMMR income_statement (annual, 2023-12-31) — Operating Income: 17927000.00
IMMR income_statement (annual, 2023-12-31) — Operating Revenue: 33919000.00
IMMR balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 31528977.00
IMMR balance_sheet (annual, 2023-12-31) — Other Current Assets: 191000.00
IMMR balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 8642000.00
IMMR balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 1702000.00
IMMR income_statement (annual, 2023-12-31) — Other Gand A: 13960000.00